Azzolini C, Patelli F, Brancato R Correlation between optical coherence tomography data and biomicroscopic interpretation of idiopathic macular hole. Am J Ophthalmol. 2001 Sep;132(3):348-55.
Dichtl A, Jonas JB, Naumann GO Histomorphometry of the optic disc in highly myopic eyes with absolute secondary angle closure glaucoma. Br J Ophthalmol. 1998 Mar;82(3):286-9.
Hyung SM, Kim DM, Hong C, Youn DH Optic disc of the myopic eye: relationship between refractive errors and morphometric characteristics. Korean J Ophthalmol. 1992 Jun;6(1):32-5.
Ishida S, Yamazaki K, Shinoda K, Kawashima S, Oguchi Y Macular hole retinal detachment in highly myopic eyes: ultrastructure of surgically removed epiretinal membrane and clinicopathologic correlation. Retina. 2000;20(2):176-83.
Jonas JB, Dichtl A Optic disc morphology in myopic primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):627-33.
Jonas JB, Gusek GC, Naumann GO Optic disk morphometry in high myopia. Graefes Arch Clin Exp Ophthalmol. 1988;226(6):587-90.
Kishi S, Hagimura N, Shimizu K The role of the premacular liquefied pocket and premacular vitreous cortex in idiopathic macular hole development. Am J Ophthalmol. 1996 Nov;122(5):622-8.
Klein R, Klein BE, Wang Q, Moss SE The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc. 1994;92:403-25; discussion 425-30.
Siam A Macular hole with central retinal detachment in high myopia with posterior staphyloma. Br J Ophthalmol. 1969 Jan;53(1):62-3.
Takano M, Kishi S Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol. 1999 Oct;128(4):472-6.
Tay MT, Au Eong KG, Ng CY, Lim MK Myopia and educational attainment in 421,116 young Singaporean males. Ann Acad Med Singapore. 1992 Nov;21(6):785-91.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.